FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Edrophonium Chloride, USP and Atropine Sulfate, USP Injection (ENLON-PLUS)
Status: Discontinuation
»Therapeutic Categories: Anesthesia

Mylan Institutional (New 12/01/2017)

Company Contact Information:
800-RXMYLAN (1-800-496-9526).

Presentation Posting Date Related Information
10 mg/mL edrophonium chloride 0.14 mg/mL atropine sulfate 5 mL Single-Dose Ampule, Box of 10 (NDC67457-192-05) 12/01/2017 Discontinuation of the manufacture of the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English